ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,322Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 201

$1.16M Total Retail Price of All Prescriptions

Rank: 5 out of 201

1,011 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,011 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

3% of this provider’s 1,011 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 9,136 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
CARVEDILOL 1,454 935 1 1
FUROSEMIDE 1,150 783 2 4
LISINOPRIL 667 463 3 2
WARFARIN SODIUM 575 387 4 11
AMLODIPINE BESYLATE 477 366 5 3
ISOSORBIDE MONONITRATE ER 468 368 6 12
SPIRONOLACTONE 315 175 7 21
DIGOXIN 309 170 8 14
POTASSIUM CHLORIDE 294 208 9 16
ATORVASTATIN CALCIUM 293 232 10 9
CLOPIDOGREL 288 212 11 7
PRAVASTATIN SODIUM 287 205 12 10
KLOR-CON M20 272 154 13 31
METOPROLOL SUCCINATE 258 186 14 6
DIOVAN 233 144 15 39
SIMVASTATIN 223 167 16 5
CRESTOR 218 156 17 17
RANEXA 210 123 18 26
TORSEMIDE 201 123 19 46
HYDROCHLOROTHIAZIDE 182 160 20 19
BYSTOLIC 182 132 20 33
PLAVIX 176 134 22 13
LOSARTAN POTASSIUM 167 123 23 15
OMEPRAZOLE 165 137 24 24
METOLAZONE 148 86 25 78
AMLODIPINE BESYLATE-BENAZEPRIL 138 114 26 48
AMIODARONE HCL 132 89 27 20
ISOSORBIDE DINITRATE 117 80 28 63
NITROSTAT 111 90 29 25
HYDRALAZINE HCL 108 66 30 27
RAMIPRIL 103 64 31 22
CITALOPRAM HBR 101 52 32 60
BIDIL 100 70 10 33 154
KLOR-CON 10 99 95 34 64
PANTOPRAZOLE SODIUM 95 69 35 37
ZETIA 95 55 35 40
GEMFIBROZIL 88 51 37 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 81 38 28
PRADAXA 70 60 39 23
COREG CR 70 40 39 114
METOPROLOL TARTRATE 67 56 41 8
LEVOTHYROXINE SODIUM 66 48 42 29
LOVASTATIN 59 59 43 74
ENALAPRIL MALEATE 59 42 43 30
PACERONE 58 52 45 79
CLONIDINE HCL 58 32 45 38
EXFORGE 54 35 47 144
ALLOPURINOL 51 30 48 59
KLOR-CON M10 50 44 49 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.